China Cord Blood Corp Revenue, Profits - CO Annual Income Statement

Add to My Stocks
$10.52 $0.2 (1.87%) CO stock closing price Feb 16, 2018 (Closing)

Fundamental analysis of CO stock involves analyzing its financial statements, apart from checking the China Cord Blood Corp stock price. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from 102.82M to 110.41M and how operating and non operating activities have impacted the CO stock. The China Cord Blood Corp profit and loss statement for 2017 shows a net profit of $18.33M. Profits for last year was $14.1M. Apart from this an investor should also check China Cord Blood Corp assets and China Cord Blood Corp free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Apr - Mar20172016201520142013201220112010
China Cord Blood Corp Revenues or Net Sales
110.41M102.82M102.45M92.15M84.71M60.41M51.85M38.31M
Cost Of Goods Sold (COGS)20.72M22.42M21.07M17.08M17.16M13.76M11.81M9.63M
China Cord Blood Corp Gross Profit
89.68M80.39M81.38M75.06M67.54M46.65M40.03M28.68M
Research & Development Expense1.5M1.39M1.59M1.57M1.36M1.2M1.06M-
Selling General & Admin Expense49.7M49.33M41.87M36.18M32.48M24.03M20.06M13.59M
Income Before Depreciation Depletion Amortization38.48M29.67M37.9M37.3M33.7M21.41M18.9M14.23M
Depreciation Depletion Amortization--------
Non Operating Income3.03M8.98M3.42M4.67M3.05M3.18M1.66M-2.21M
Interest Expense17.34M16.74M16.3M11.27M11.28M---
China Cord Blood Corp Pretax Income
24.16M21.91M25.02M30.71M25.47M24.07M20.17M11.67M
Provision for Income Taxes5.46M7.75M7.63M9.39M6.2M1.53M5.18M3.62M
MinorityInterest----1.15M1.58M--
Investment Gains Losses--------
Other Income--------
Income Before Extraordinaries & Disc Operations18.69M14.16M17.38M21.31M19.26M22.54M14.99M8.04M
Extraordinary Items & Discontinued Operations--------
China Cord Blood Corp Profit/ Loss (Net Income)
18.33M14.1M17.3M21.21M18.1M20.95M14M7.2M
Average Shares used to compute Diluted EPS79.71M73M78.67M81.61M75.44M74.85M70.02M-
Average Shares used to compute Basic EPS79.71M73M78.67M81.61M75.44M74.85M70.02M-
Income Before Nonrecurring Items18.33M14.11M17.31M21.22M18.11M20.96M14M-
Income from Nonrecurring Items--------
China Cord Blood Corp Earnings Per Share Basic Net
0.230.190.220.260.240.280.200.18
China Cord Blood Corp Earnings Per Share Diluted Net
--------
EPS Diluted Before Nonrecurring Items0.230.190.220.260.240.280.200.15
Preferred Dividends Acc Pd--------
Dividends Common--------
Dividend Per Share Common0.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

China Cord Blood Corp stock analysis involves checking at least a few of the important things like:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that CO stock has a topline or revenue of $110.41M for 2017 as per this China Cord Blood Corp revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. CO stock had a healthy bottom line growth.

The income statement is also called the profit and loss statement. Apart from the CO income statement, one can check the China Cord Blood Corp historical stock prices to check how the price has moved with time.

China Cord Blood Corp Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
30.06
PS Ratio (price sales ratio)
9.38
Operating Margin
32.5
Net Profit Margin
28.8
Dividend Yield
0%